InterMune Lung Drug Is Successful In New Trial
Wednesday, February 26, 2014 - 21:30
in Health & Medicine
The company said it would apply for United States regulatory approval of pirfenidone to treat idiopathic pulmonary fibrosis, a scarring of the lungs.
